BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 6423650)

  • 1. Galactosyltransferase activity and cell growth: uridine diphosphate (UDP)galactose inhibition of murine leukemic L1210 cells.
    Klohs WD; Wilson JR; Weiser MM; Frankfurt O; Bernacki RJ
    J Cell Physiol; 1984 Apr; 119(1):23-8. PubMed ID: 6423650
    [TBL] [Abstract][Full Text] [Related]  

  • 2. UDP-galactose inhibition of BALB/3T12-3 cell growth. Requirement for medium galactosyltransferase activity.
    Klohs WD; Wilson JR; Weiser MM
    Exp Cell Res; 1982 Oct; 141(2):365-74. PubMed ID: 6814933
    [No Abstract]   [Full Text] [Related]  

  • 3. Characterization of L1210 cell growth inhibition by the bacterial iron chelators parabactin and compound II.
    Cavanaugh PF; Porter CW; Tukalo D; Frankfurt OS; Pavelic ZP; Bergeron RJ
    Cancer Res; 1985 Oct; 45(10):4754-9. PubMed ID: 4027962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. UDPgalactose inhibits blastocyst formation in the mouse. Implications for the mode of action of T/t-complex mutations.
    Shur BD; Oettgen P; Bennett D
    Dev Biol; 1979 Nov; 73(1):178-81. PubMed ID: 118894
    [No Abstract]   [Full Text] [Related]  

  • 5. Cytotoxic effects of dihydroorotase inhibitors upon human CCRF-CEM leukemia.
    Brooke J; Szabados E; Lyons SD; Goodridge RJ; Harsanyi MC; Poiner A; Christopherson RI
    Cancer Res; 1990 Dec; 50(24):7793-8. PubMed ID: 1979249
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of the P2Y14 receptor in human neutrophils.
    Scrivens M; Dickenson JM
    Eur J Pharmacol; 2006 Aug; 543(1-3):166-73. PubMed ID: 16820147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Existence of UDP galactose: galactosyltransferase activity at the external surface of cultured neurons].
    Matsui Y; Lombard D; Hoflack B; Harth S; Massarelli R; Mandel P; Dreyfus H
    C R Seances Acad Sci III; 1983; 296(12):563-7. PubMed ID: 6409364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of phytohemagglutinin isolectins L4 and E4 on L1210 cells.
    Egorin MJ; Odders RN; Sanel FT; Felsted RL; Bachur NR
    Cancer Res; 1978 Jun; 38(6):1677-87. PubMed ID: 565679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The biochemical and ultrastructural effects of tunicamycin and D-glucosamine in L1210 leukemic cells.
    Morin MJ; Porter CW; McKernan P; Bernacki RJ
    J Cell Physiol; 1983 Feb; 114(2):162-72. PubMed ID: 6822608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the L isomer (+)-1,2-bis(3,5-dioxopiperazine-1-yl)propane on cell survival and cell cycle progression of cultured mammalian cells.
    Traganos F; Darzynkiewicz Z; Melamed MR
    Cancer Res; 1981 Nov; 41(11 Pt 1):4566-76. PubMed ID: 6171341
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cellular pharmacology in murine and human leukemic cell lines of diaziquone (NSC 182986).
    Egorin MJ; Fox BM; Spiegel JF; Gutierrez PL; Friedman RD; Bachur NR
    Cancer Res; 1985 Mar; 45(3):992-9. PubMed ID: 3971389
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultraviolet photoinactivation of galactosyltransferase. Protection by substrates.
    Clymer DJ; Geren CR; Ebner KE
    Biochemistry; 1976 Mar; 15(5):1093-7. PubMed ID: 1252429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of CMP-N-acetylneuraminic acid:lactosylceramide sialyltransferase by nucleotides, nucleotide sugars and nucleotide dialdehydes.
    Cambron LD; Leskawa KC
    Biochem Biophys Res Commun; 1993 Jun; 193(2):585-90. PubMed ID: 8512559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Galactolipid formation in chloroplast envelopes. I. Evidence for two mechanisms in galactosylation.
    van Besouw A; Wintermans JF
    Biochim Biophys Acta; 1978 Apr; 529(1):44-53. PubMed ID: 638180
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of N-hydroxy-N'-aminoguanidine derivatives on ribonucleotide reductase activity, nucleic acid synthesis, clonogenicity, and cell cycle of L1210 cells.
    Weckbecker G; Weckbecker A; Lien EJ; Cory JG
    Cancer Res; 1987 Feb; 47(4):975-8. PubMed ID: 2433036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Release of glycosyltransferase and glycosidase activities from normal and transformed cell lines.
    Klohs WD; Mastrangelo R; Weiser MM
    Cancer Res; 1981 Jul; 41(7):2611-5. PubMed ID: 6788358
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reversal of methotrexate inhibition of colony growth of L1210 leukemia cells in semisolid medium.
    Nederbragt H; Uitendaal MP; van der Grint L; Leyva A; Pinedo HM
    Cancer Res; 1981 Mar; 41(3):1193-8. PubMed ID: 6970074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uridine diphosphate hexoses in leukocytes and fibroblasts of classic galactosemics and patients with other metabolic diseases.
    Gibson JB; Reynolds RA; Palmieri MJ; States B; Berry GT; Segal S
    Pediatr Res; 1994 Nov; 36(5):613-8. PubMed ID: 7877880
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cytotoxic effects of dexamethasone restricted to noncycling, early G1-phase cells of L1210 leukemia.
    Smets LA; Bout B; Brouwer M; Tulp A
    J Cell Physiol; 1983 Sep; 116(3):397-403. PubMed ID: 6885934
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Injury of neoplastic cells by murine macrophages leads to inhibition of mitochondrial respiration.
    Granger DL; Taintor RR; Cook JL; Hibbs JB
    J Clin Invest; 1980 Feb; 65(2):357-70. PubMed ID: 7356685
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.